HU175186B - Sposob poluchenija novykh proizvodnykh eritromicina - Google Patents
Sposob poluchenija novykh proizvodnykh eritromicinaInfo
- Publication number
- HU175186B HU175186B HU76TO1026A HUTO001026A HU175186B HU 175186 B HU175186 B HU 175186B HU 76TO1026 A HU76TO1026 A HU 76TO1026A HU TO001026 A HUTO001026 A HU TO001026A HU 175186 B HU175186 B HU 175186B
- Authority
- HU
- Hungary
- Prior art keywords
- producing new
- erythromycin derivatives
- new erythromycin
- derivatives
- producing
- Prior art date
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2515075A DE2515075C2 (de) | 1975-04-07 | 1975-04-07 | Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE19762606030 DE2606030A1 (de) | 1976-02-14 | 1976-02-14 | Neue erythromycinderivate und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU175186B true HU175186B (hu) | 1980-05-28 |
Family
ID=25768725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU76TO1026A HU175186B (hu) | 1975-04-07 | 1976-04-06 | Sposob poluchenija novykh proizvodnykh eritromicina |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US4048306A (en, 2012) |
| JP (1) | JPS51128991A (en, 2012) |
| AT (1) | AT342770B (en, 2012) |
| AU (1) | AU498418B2 (en, 2012) |
| BG (1) | BG27380A3 (en, 2012) |
| CA (1) | CA1060005A (en, 2012) |
| CH (2) | CH621800A5 (en, 2012) |
| CS (1) | CS196304B2 (en, 2012) |
| DD (1) | DD125218A5 (en, 2012) |
| DK (1) | DK138656C (en, 2012) |
| ES (2) | ES446737A1 (en, 2012) |
| FI (1) | FI63244C (en, 2012) |
| FR (1) | FR2306703A1 (en, 2012) |
| GB (1) | GB1520963A (en, 2012) |
| GR (1) | GR60374B (en, 2012) |
| HU (1) | HU175186B (en, 2012) |
| IE (1) | IE43598B1 (en, 2012) |
| IL (1) | IL49359A (en, 2012) |
| LU (2) | LU88563I2 (en, 2012) |
| MX (1) | MX3277E (en, 2012) |
| NL (1) | NL180107C (en, 2012) |
| NO (1) | NO141411C (en, 2012) |
| NZ (1) | NZ180529A (en, 2012) |
| PL (1) | PL101880B1 (en, 2012) |
| PT (1) | PT64977B (en, 2012) |
| RO (1) | RO68441B (en, 2012) |
| SE (1) | SE425566B (en, 2012) |
| SU (1) | SU682134A3 (en, 2012) |
| YU (1) | YU87676A (en, 2012) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4847242A (en) | 1985-03-12 | 1989-07-11 | Beecham Group P.L.C. | 11-ether derivatives of erythromycins |
| DE3524572A1 (de) * | 1985-07-10 | 1987-01-15 | Thomae Gmbh Dr K | Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung |
| US5110800A (en) * | 1986-02-18 | 1992-05-05 | Eli Lilly And Company | Derivatives of erythromycylamine |
| US4945080A (en) * | 1987-05-26 | 1990-07-31 | Eli Lilly And Company | Dirithromycin metabolite |
| US5075289A (en) * | 1988-06-07 | 1991-12-24 | Abbott Laboratories | 9-r-azacyclic erythromycin antibiotics |
| US5403923A (en) * | 1990-11-28 | 1995-04-04 | Taisho Pharmaceutical Co., Ltd. | 6-0-methylerythromycin A derivatives |
| ZA922777B (en) * | 1991-04-29 | 1993-10-15 | Lilly Co Eli | Pharmaceutical formulation containing dirithromycin |
| US5556839A (en) * | 1991-04-29 | 1996-09-17 | Eli Lilly And Company | Form II Dirithromycin |
| ZA927328B (en) * | 1991-09-30 | 1994-03-24 | Lilly Co Eli | One step process for production of dirithromycin |
| US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
| DE4410637C1 (de) * | 1994-03-26 | 1995-09-21 | Boehringer Ingelheim Vetmed | Injizierbare Lösungen von Dirithromycin |
| FR2718450B1 (fr) * | 1994-04-08 | 1997-01-10 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| FR2719587B1 (fr) * | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| WO1999021867A1 (fr) * | 1997-10-29 | 1999-05-06 | Taisho Pharmaceutical Co., Ltd. | Derives d'erythromycine a |
| US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
| US6565882B2 (en) | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
| US6541014B2 (en) | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
| US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
| US6436906B1 (en) | 2001-04-02 | 2002-08-20 | Enanta Pharmaceuticals, Inc. | 9-amino-14-membered macrolides derived from leucomycins |
| EP1648415A4 (en) | 2003-07-21 | 2011-11-16 | Middlebrook Pharmaceuticals Inc | ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION |
| JP2006528190A (ja) | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
| JP2006528185A (ja) | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
| AU2004264939A1 (en) | 2003-08-11 | 2005-02-24 | Middlebrook Pharmaceuticals, Inc. | Robust pellet |
| WO2005016278A2 (en) | 2003-08-12 | 2005-02-24 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
| US8246996B2 (en) * | 2003-08-29 | 2012-08-21 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
| CA2538064C (en) | 2003-09-15 | 2013-12-17 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
| JP2008505124A (ja) | 2004-07-02 | 2008-02-21 | アドバンシス ファーマスーティカル コーポレイション | パルス送達用錠剤 |
| US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
| US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
| US8299052B2 (en) * | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3660376A (en) * | 1970-09-30 | 1972-05-02 | Lilly Co Eli | N-arylidene erythromycylamines |
-
1976
- 1976-03-01 AT AT149976A patent/AT342770B/de not_active IP Right Cessation
- 1976-03-26 GR GR50399A patent/GR60374B/el unknown
- 1976-03-29 US US05/671,421 patent/US4048306A/en not_active Expired - Lifetime
- 1976-03-29 BG BG032727A patent/BG27380A3/xx unknown
- 1976-03-30 FI FI760845A patent/FI63244C/fi not_active IP Right Cessation
- 1976-03-30 DK DK145276A patent/DK138656C/da not_active IP Right Cessation
- 1976-04-02 CH CH417476A patent/CH621800A5/de not_active IP Right Cessation
- 1976-04-05 LU LU88563C patent/LU88563I2/fr unknown
- 1976-04-05 LU LU74702A patent/LU74702A1/xx unknown
- 1976-04-05 DD DD192208A patent/DD125218A5/xx unknown
- 1976-04-06 JP JP51038681A patent/JPS51128991A/ja active Granted
- 1976-04-06 PT PT64977A patent/PT64977B/pt unknown
- 1976-04-06 PL PL1976188538A patent/PL101880B1/pl unknown
- 1976-04-06 HU HU76TO1026A patent/HU175186B/hu unknown
- 1976-04-06 RO RO85433A patent/RO68441B/ro unknown
- 1976-04-06 NO NO761172A patent/NO141411C/no unknown
- 1976-04-06 IL IL49359A patent/IL49359A/xx unknown
- 1976-04-06 SE SE7604052A patent/SE425566B/xx not_active IP Right Cessation
- 1976-04-06 MX MX000145U patent/MX3277E/es unknown
- 1976-04-06 SU SU762343016A patent/SU682134A3/ru active
- 1976-04-06 CA CA249,700A patent/CA1060005A/en not_active Expired
- 1976-04-06 NZ NZ180529A patent/NZ180529A/xx unknown
- 1976-04-06 AU AU12722/76A patent/AU498418B2/en not_active Expired
- 1976-04-06 ES ES446737A patent/ES446737A1/es not_active Expired
- 1976-04-06 CS CS762265A patent/CS196304B2/cs unknown
- 1976-04-06 NL NLAANVRAGE7603569,A patent/NL180107C/xx not_active IP Right Cessation
- 1976-04-06 YU YU00876/76A patent/YU87676A/xx unknown
- 1976-04-06 GB GB13942/76A patent/GB1520963A/en not_active Expired
- 1976-04-07 FR FR7610144A patent/FR2306703A1/fr active Granted
- 1976-04-07 IE IE732/76A patent/IE43598B1/en not_active IP Right Cessation
-
1977
- 1977-03-05 ES ES456567A patent/ES456567A1/es not_active Expired
-
1980
- 1980-04-10 CH CH277580A patent/CH624413A5/de not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU175186B (hu) | Sposob poluchenija novykh proizvodnykh eritromicina | |
| HU172697B (hu) | Sposob poluchenija proizvodnykh tieno-skobka-2,3-c-skobka zakryta-piridina | |
| HU178128B (en) | Process for producing corticosteroides | |
| HU177970B (en) | Process for producing new glucosamine derivatives | |
| HU172176B (hu) | Sposob poluchenija proizvodnykh tienopiridina | |
| HU174850B (hu) | Sposob poluchenija slozhnykh 17-al'fa-efirov 21-galogeno-pregnanov | |
| HU175369B (hu) | Sposob poluchneija novykh proizvodnykh 16-degidro-androstana | |
| HU177817B (en) | Process for producing 3,4-dihydroquinasoline derivatives | |
| HU173693B (hu) | Sposob poluchenija zamehhennykh proizvodnykh tieno-benzodiazepina | |
| HU172483B (hu) | Sposob poluchenija benzimidazol-karbamatov | |
| HU179275B (en) | Process for producing 11-deoxy-16-aryloxy-omega-tetra prrostaglandines | |
| HU174191B (hu) | Sposob poluchenija soedinenijj acilamino-oksadiazola i -tiadiazola | |
| HU171083B (hu) | Sposob poluchenija l-3-skobka-3-zapjataja vverkh-zapjataja vniz-4-zapjataja vverkh-digidroksi-fenil-skobka zakryta-2-metil-alanin-peptidov | |
| HU175422B (hu) | Sposob poluchenija novykh proizvodnykh 11-okso-prostaglandinov | |
| HU172441B (hu) | Sposob poluchenija omega-skobka-arilsul'fonamido-skobka | |
| HU178337B (en) | Process for producing chlorothioformic acid-ethyl-esters | |
| HU173926B (hu) | Sposob poluchenija 3-fenoksi-benzaldehidov | |
| HU174587B (hu) | Sposob poluchenija proizvodnykh tiazolidinov | |
| HU171663B (hu) | Sposob poluchenija novykh proizvodnykh 14-skobka-zamehhennogo metil-skobka zakryta-vinkana | |
| HU172729B (hu) | Sposob poluchenija novykh cefem-soedinenijj | |
| HU177770B (en) | Process for producing 2,2-difluoro-prostaglandine derivatives | |
| HU172055B (hu) | Sposob poluchenija proizvodnykh tieno-skobka-3,2-c-skobka zakryta-piridina | |
| HU172063B (hu) | Sposob poluchenija priozvodnykh n-skobka-5-tetrazolil-skobka zakryta-1-okso-6-alkoksi-1h-pirimido-skobka-1,2-a-skobka zakryta-kinolin-2-karboksamidov | |
| HU172481B (hu) | Sposob poluchenija 2-alkil-indanov | |
| HU172549B (hu) | Sposob poluchenija proizvodnykh 3-tetrazolil-gamma-kromona |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HU90 | Patent valid on 900628 |